DENVER, Jan. 26, 2022 /PRNewswire/ -- Infermedica, a
leading digital health company, specializing in AI-powered
solutions for symptom analysis and patient triage, today announces
a $30 million Series B funding round,
led by One Peak, and supported by previous investors: Karma
Ventures, European Bank for Reconstruction and Development, Heal
Capital, and Inovo Venture Partners. The new investment – which
follows a Series A funding round just over a year ago – brings the
company's total funding to $44
million. The capital will be used to support Infermedica in
tackling some of the biggest issues facing healthcare through
further development of their Medical Guidance Platform (MGP) and
adding new modules to cover the full primary care journey.
Infermedica will also increase their global commercial presence and
expand their international, remote-first team of industry and
medical experts.
"We are incredibly excited to back the Infermedica team as we share
their vision of making healthcare more accessible."
"We are incredibly excited to back the Infermedica team as we
share their vision of making healthcare more accessible and
affordable by automating primary care. We have been particularly
impressed with Infermedica's clinical safety and accuracy,
best-in-class user experience, ease of deployment, and customer
service. We believe the company has all the ingredients in place to
become the global standard for using AI to support patients and
healthcare providers in all steps of the primary care journey and
we look forward to supporting Infermedica in its next phase of
explosive growth."
- Humbert de Liedekerke, Managing
Partner, One Peak
By 2030, up to 5 billion people will be unable to access
even basic healthcare, mainly due to provider shortages and
burnout. Infermedica's mission is to ease the strain on global
healthcare systems and make healthcare accessible, convenient and
affordable by automating primary care. Infermedica's MGP is the
first step to achieving this vision by supporting and streamlining
the healthcare decision-making process, from symptom to
outcome.
MGP leverages the same technology behind Infermedica's
successful Symptom Checker tool, which has been used by over 10
million users globally, to triage patients to the right level of
care. Infermedica plans to further develop the solution to enable
seamless handover to providers, including EHR integration, as part
of the intake process, as well as automating follow-ups to close
the feedback loop. In the US alone, administrative simplification
could reduce healthcare spending by over a quarter-trillion dollars
($265 billion) annually.
Founded in 2012 in Poland by
Piotr Orzechowski (CEO),
Infermedica's team grew by 80% in 2021 to 180 specialists –
including physicians, data scientists, and engineers, and 2022 will
see Infermedica on the trajectory to double their workforce yet
again.
"We're thrilled to partner with One Peak as the lead investor
for this round. From the moment we met, we were very impressed with
One Peak's open and honest approach and felt that we share very
similar values. One Peak is a high value-add partner for us with
extensive experience in scaling B2B companies. I'm also thankful to
our existing investors for their continued support and
participation in our Series B round. To date, we've spent over
60,000 hours of physicians' work building one of the world's most
advanced medical knowledge bases of diseases, symptoms, and risk
factors. We will deploy the new funds to execute our vision of
making primary care more efficient and affordable by creating
constantly improving AI technology for everyone on the planet."
- Piotr
Orzechowski, CEO and Co-Founder, Infermedica
With the development of their Medical Guidance Platform
underway, Infermedica is proud to be continuing their growth story
as part of the One Peak investment portfolio.
About Infermedica
Infermedica is a leading digital health company, specializing in
AI-powered solutions for symptom analysis and patient triage. The
company's mission is to make healthcare accessible, convenient and
affordable for everyone worldwide, by automating primary care, from
symptom to outcome.
Infermedica has been adeptly interweaving medical and technical
expertise into their technologies since 2012, to support industry
leaders including Allianz, Global Excel, Gothaer, Microsoft, Optum,
and Sana Kliniken. Infermedica is now being used in more than 30
countries, in 19 languages, and has completed more than 10 million
successful health checks to date. To learn more, visit
www.infermedica.com
About One Peak
One Peak is a growth equity firm investing in technology
companies in the scale-up phase. One Peak provides growth capital,
operating expertise and access to its extensive network to
exceptional entrepreneurs, with a view to help transform innovative
and rapidly growing businesses into lasting, category-defining
leaders. In addition to Infermedica, One Peak's investments include
Neo4j, DocPlanner, Spryker Systems, PandaDoc, Keepit, Cymulate,
Paysend, HighQ, Quentic, Coople, DataGuard, Brightflag and many
more. To learn more, visit www.onepeakpartners.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/infermedica-raises-30-million-series-b-funding-from-one-peak-to-expand-ai-driven-medical-guidance-platform-301468118.html
SOURCE Infermedica